Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer
This study has been completed.
Sponsor:
Samsung Medical Center
Information provided by (Responsible Party):
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01238055
First received: January 7, 2010
Last updated: April 8, 2013
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |